Breakthroughs in understanding and treating eosinophilic gastrointestinal diseases presented at the CEGIR/TIGERs Symposium at the 2022 American Academy of Allergy, Asthma & Immunology Meeting
Copyright © 2023 American Academy of Allergy, Asthma & Immunology. All rights reserved..
The Consortium of Eosinophilic Gastrointestinal Diseases and The International Gastrointestinal Eosinophil Researchers organized a day-long symposium at the 2022 Annual Meeting of the American Academy of Allergy, Asthma & Immunology. The symposium featured a review of recent discoveries in the basic biology and pathogenesis of eosinophilic gastrointestinal diseases (EGIDs) in addition to advances in our understanding of the clinical features of EGIDs. Diagnostic and management approaches were reviewed and debated, and clinical trials of emerging therapies were highlighted. Herein, we briefly summarize the breakthrough discoveries in EGIDs.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:152 |
|---|---|
| Enthalten in: |
The Journal of allergy and clinical immunology - 152(2023), 6 vom: 23. Dez., Seite 1382-1393 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Chehade, Mirna [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Eosinophil |
|---|
| Anmerkungen: |
Date Completed 16.12.2023 Date Revised 30.01.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.jaci.2023.08.021 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM361587090 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM361587090 | ||
| 003 | DE-627 | ||
| 005 | 20240130232030.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jaci.2023.08.021 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1275.xml |
| 035 | |a (DE-627)NLM361587090 | ||
| 035 | |a (NLM)37660987 | ||
| 035 | |a (PII)S0091-6749(23)01103-X | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Chehade, Mirna |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Breakthroughs in understanding and treating eosinophilic gastrointestinal diseases presented at the CEGIR/TIGERs Symposium at the 2022 American Academy of Allergy, Asthma & Immunology Meeting |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 16.12.2023 | ||
| 500 | |a Date Revised 30.01.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2023 American Academy of Allergy, Asthma & Immunology. All rights reserved. | ||
| 520 | |a The Consortium of Eosinophilic Gastrointestinal Diseases and The International Gastrointestinal Eosinophil Researchers organized a day-long symposium at the 2022 Annual Meeting of the American Academy of Allergy, Asthma & Immunology. The symposium featured a review of recent discoveries in the basic biology and pathogenesis of eosinophilic gastrointestinal diseases (EGIDs) in addition to advances in our understanding of the clinical features of EGIDs. Diagnostic and management approaches were reviewed and debated, and clinical trials of emerging therapies were highlighted. Herein, we briefly summarize the breakthrough discoveries in EGIDs | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Eosinophilic esophagitis | |
| 650 | 4 | |a eosinophil | |
| 650 | 4 | |a eosinophilic gastritis | |
| 650 | 4 | |a food allergy | |
| 700 | 1 | |a Wright, Benjamin L |e verfasserin |4 aut | |
| 700 | 1 | |a Atkins, Dan |e verfasserin |4 aut | |
| 700 | 1 | |a Aceves, Seema S |e verfasserin |4 aut | |
| 700 | 1 | |a Ackerman, Steven J |e verfasserin |4 aut | |
| 700 | 1 | |a Assa'ad, Amal H |e verfasserin |4 aut | |
| 700 | 1 | |a Bauer, Maureen |e verfasserin |4 aut | |
| 700 | 1 | |a Collins, Margaret H |e verfasserin |4 aut | |
| 700 | 1 | |a Commins, Scott P |e verfasserin |4 aut | |
| 700 | 1 | |a Davis, Carla M |e verfasserin |4 aut | |
| 700 | 1 | |a Dellon, Evan S |e verfasserin |4 aut | |
| 700 | 1 | |a Doerfler, Bethan |e verfasserin |4 aut | |
| 700 | 1 | |a Gleich, Gerald J |e verfasserin |4 aut | |
| 700 | 1 | |a Gupta, Sandeep K |e verfasserin |4 aut | |
| 700 | 1 | |a Hill, David A |e verfasserin |4 aut | |
| 700 | 1 | |a Jensen, Elizabeth T |e verfasserin |4 aut | |
| 700 | 1 | |a Katzka, David |e verfasserin |4 aut | |
| 700 | 1 | |a Kliewer, Kara |e verfasserin |4 aut | |
| 700 | 1 | |a Kodroff, Ellyn |e verfasserin |4 aut | |
| 700 | 1 | |a Kottyan, Leah C |e verfasserin |4 aut | |
| 700 | 1 | |a Kyle, Shay |e verfasserin |4 aut | |
| 700 | 1 | |a Muir, Amanda B |e verfasserin |4 aut | |
| 700 | 1 | |a Pesek, Robert D |e verfasserin |4 aut | |
| 700 | 1 | |a Peterson, Kathryn |e verfasserin |4 aut | |
| 700 | 1 | |a Shreffler, Wayne G |e verfasserin |4 aut | |
| 700 | 1 | |a Spergel, Jonathan M |e verfasserin |4 aut | |
| 700 | 1 | |a Strobel, Mary Jo |e verfasserin |4 aut | |
| 700 | 1 | |a Wechsler, Joshua |e verfasserin |4 aut | |
| 700 | 1 | |a Zimmermann, Nives |e verfasserin |4 aut | |
| 700 | 1 | |a Furuta, Glenn T |e verfasserin |4 aut | |
| 700 | 1 | |a Rothenberg, Marc E |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Journal of allergy and clinical immunology |d 1971 |g 152(2023), 6 vom: 23. Dez., Seite 1382-1393 |w (DE-627)NLM000018449 |x 1097-6825 |7 nnns |
| 773 | 1 | 8 | |g volume:152 |g year:2023 |g number:6 |g day:23 |g month:12 |g pages:1382-1393 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jaci.2023.08.021 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 152 |j 2023 |e 6 |b 23 |c 12 |h 1382-1393 | ||